ACCESSION: MSBNK-SMB_Measured-HSA001P0324008
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 108
COMMENT: RAW_SPEC {'BLK01_13761': {'bp': 43637.0, 'sum': 142091.0}, '13_posi_14188': {'bp': 25145.0, 'sum': 86634.0}, '14_posi_13237': {'bp': 26072.0, 'sum': 77728.0}, '8_posi_13389': {'bp': 27580.0, 'sum': 85551.0}, '2_posi_13912': {'bp': 29623.0, 'sum': 91549.0}, '15_posi_14247': {'bp': 29850.0, 'sum': 96714.0}, '2_posi_13705': {'bp': 30704.0, 'sum': 125990.0}, '15_posi_14121': {'bp': 31138.0, 'sum': 136805.0}, '10_posi_13974': {'bp': 32011.0, 'sum': 108252.0}, 'BLK01_13512': {'bp': 33051.0, 'sum': 119065.0}, '3_posi_13678': {'bp': 33205.0, 'sum': 122605.0}, '9_posi_13888': {'bp': 27189.0, 'sum': 81959.0}, '2_posi_14224': {'bp': 27457.0, 'sum': 97090.0}, 'BLK01_13572': {'bp': 29740.0, 'sum': 97412.0}, '5_posi_14246': {'bp': 32399.0, 'sum': 123062.0}, '6_posi_13053': {'bp': 32436.0, 'sum': 115341.0}, '3_posi_14141': {'bp': 35876.0, 'sum': 120267.0}, '17_posi_13343': {'bp': 37757.0, 'sum': 123315.0}, 'BLK02_13261': {'bp': 38146.0, 'sum': 144672.0}, '11_posi_13092': {'bp': 38977.0, 'sum': 114288.0}, '3_posi_14016': {'bp': 26609.0, 'sum': 72783.0}, '9_posi_13489': {'bp': 26780.0, 'sum': 72037.0}, '10_posi_13325': {'bp': 28745.0, 'sum': 101294.0}, '16_posi_13914': {'bp': 28953.0, 'sum': 101683.0}, '8_posi_13786': {'bp': 29123.0, 'sum': 94302.0}, 'ProcedureBlank_14184': {'bp': 29423.0, 'sum': 98321.0}, '10_posi_13452': {'bp': 29502.0, 'sum': 119416.0}, '12_posi_14039': {'bp': 30133.0, 'sum': 98041.0}, '2_posi_13177': {'bp': 31167.0, 'sum': 112636.0}, '13_posi_13932': {'bp': 32970.0, 'sum': 133833.0}, '4_posi_13346': {'bp': 35979.0, 'sum': 128955.0}, '8_posi_14244': {'bp': 23345.0, 'sum': 77326.0}, '8_posi_13532': {'bp': 28243.0, 'sum': 92905.0}, '4_posi_13912': {'bp': 30852.0, 'sum': 118423.0}, '4_posi_13700': {'bp': 32233.0, 'sum': 103852.0}, 'BLK01_14142': {'bp': 39786.0, 'sum': 122161.0}, '7_posi_14227': {'bp': 23561.0, 'sum': 83207.0}, '12_posi_13975': {'bp': 28078.0, 'sum': 99345.0}, '10_posi_13134': {'bp': 28255.0, 'sum': 95301.0}, '13_posi_13641': {'bp': 28430.0, 'sum': 84316.0}, '17_posi_13787': {'bp': 28478.0, 'sum': 95655.0}, '12_posi_13477': {'bp': 31003.0, 'sum': 96467.0}, '8_posi_13721': {'bp': 33208.0, 'sum': 115198.0}, 'BLK01_14078': {'bp': 39682.0, 'sum': 144086.0}, '7_posi_14016': {'bp': 29216.0, 'sum': 102279.0}, '10_posi_13386': {'bp': 31666.0, 'sum': 110256.0}, '3_posi_14403': {'bp': 33954.0, 'sum': 142930.0}, '9_posi_14384': {'bp': 35447.0, 'sum': 127630.0}, '7_posi_13321': {'bp': 28237.0, 'sum': 109094.0}, '3_posi_14269': {'bp': 24345.0, 'sum': 95488.0}, '12_posi_13242': {'bp': 35439.0, 'sum': 115655.0}, '2_posi_13322': {'bp': 34552.0, 'sum': 145119.0}, '1_posi_13240': {'bp': 33442.0, 'sum': 114288.0}, '10_posi_13197': {'bp': 32368.0, 'sum': 90490.0}, '6_posi_13638': {'bp': 29834.0, 'sum': 102884.0}, '7_posi_13764': {'bp': 29557.0, 'sum': 99638.0}, '6_posi_14098': {'bp': 26951.0, 'sum': 100952.0}, '6_posi_14164': {'bp': 23005.0, 'sum': 73022.0}, '10_posi_13910': {'bp': 36739.0, 'sum': 116325.0}, '1_posi_14038': {'bp': 36383.0, 'sum': 128398.0}, '12_posi_14225': {'bp': 34449.0, 'sum': 92801.0}, '5_posi_14102': {'bp': 32258.0, 'sum': 100431.0}, '16_posi_13280': {'bp': 30375.0, 'sum': 98533.0}, 'ProcedureBlank_13784': {'bp': 30220.0, 'sum': 94528.0}, '2_posi_14063': {'bp': 29922.0, 'sum': 104134.0}, '17_posi_13620': {'bp': 29110.0, 'sum': 67773.0}, '2_posi_13995': {'bp': 27666.0, 'sum': 85298.0}, 'ProcedureBlank_13995': {'bp': 27306.0, 'sum': 120954.0}, '3_posi_13934': {'bp': 25000.0, 'sum': 95744.0}, 'BLK01_13638': {'bp': 38862.0, 'sum': 124462.0}, 'BLK01_13134': {'bp': 35025.0, 'sum': 141081.0}, '5_posi_13848': {'bp': 34711.0, 'sum': 139193.0}, '2_posi_13639': {'bp': 33138.0, 'sum': 131956.0}, '13_posi_14266': {'bp': 32762.0, 'sum': 112386.0}, '15_posi_14186': {'bp': 31759.0, 'sum': 95973.0}, '6_posi_14226': {'bp': 31004.0, 'sum': 119968.0}, '19_posi_13181': {'bp': 30342.0, 'sum': 99218.0}, '1_posi_13302': {'bp': 30316.0, 'sum': 116810.0}, '1_posi_13177': {'bp': 25981.0, 'sum': 106230.0}, '19_posi_13391': {'bp': 25558.0, 'sum': 73861.0}, '7_posi_13177': {'bp': 22230.0, 'sum': 86804.0}, 'BLK02_13805': {'bp': 33320.0, 'sum': 109573.0}, '8_posi_13932': {'bp': 31998.0, 'sum': 153678.0}, '17_posi_14122': {'bp': 31102.0, 'sum': 95419.0}, '12_posi_13763': {'bp': 30926.0, 'sum': 121376.0}, 'BLK01_13887': {'bp': 30769.0, 'sum': 122435.0}, '5_posi_13598': {'bp': 29867.0, 'sum': 105747.0}, '10_posi_14104': {'bp': 29341.0, 'sum': 92140.0}, '10_posi_13742': {'bp': 28223.0, 'sum': 115968.0}, '4_posi_13220': {'bp': 27375.0, 'sum': 107532.0}, 'BLK01_13447': {'bp': 34291.0, 'sum': 126381.0}, 'ProcedureBlank_13196': {'bp': 33003.0, 'sum': 108308.0}, '4_posi_14081': {'bp': 30152.0, 'sum': 96992.0}, '6_posi_13891': {'bp': 30121.0, 'sum': 99996.0}, '3_posi_13406': {'bp': 27198.0, 'sum': 103846.0}, '1_posi_13492': {'bp': 40557.0, 'sum': 179886.0}, 'BLK01_13700': {'bp': 33192.0, 'sum': 119034.0}, '4_posi_13471': {'bp': 32176.0, 'sum': 113825.0}, '2_posi_14143': {'bp': 29303.0, 'sum': 88617.0}, '15_posi_14057': {'bp': 28239.0, 'sum': 94876.0}, '3_posi_13279': {'bp': 42582.0, 'sum': 152805.0}, '1_posi_14165': {'bp': 34558.0, 'sum': 127120.0}, 'ProcedureBlank_13704': {'bp': 30264.0, 'sum': 125117.0}, '10_posi_14186': {'bp': 27895.0, 'sum': 109816.0}, '2_posi_13575': {'bp': 23086.0, 'sum': 83312.0}, '1_posi_14101': {'bp': 30016.0, 'sum': 122897.0}, '13_posi_13196': {'bp': 29011.0, 'sum': 133364.0}, 'BLK01_13950': {'bp': 32450.0, 'sum': 133566.0}}
COMMENT: RETENTION_TIME_STDEV 0.744
COMMENT: PRECURSOR_M/Z_RAW 324.216278
COMMENT: PRECURSOR_M/Z_STDEV 0.000110
COMMENT: PRECURSOR_IN_MS1 mz 324.216936; int 29.902; delta(ppm) 1.387859
COMMENT: PROPOSED_CHARGE_STATE +1; mz 325.220433; int 5.382; cor 0.740
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.000; C18H29NO4; [M+H]+; delta(ppm) -0.000000
COMMENT: PROPOSED_MF MS-FINDER 3.975; C18H29NO4; [M+H]+; delta(ppm) -0.002629
COMMENT: PROPOSED_MF MS-FINDER 1.546; C11H37N3OS3; [M+H]+; delta(ppm) -0.673180
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.939; C18H29NO4; [M+H]+; delta(ppm) -0.002629
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.781; C14H25N7O2; [M+H]+; delta(ppm) 8.279941
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.115; C12H30N5O3P; [M+H]+; delta(ppm) 3.185248
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.102; C15H31O7; [M+H]+; delta(ppm) 8.263749
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.938; C13H30ClN5O2; [M+H]+; delta(ppm) -68920.268394
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.809; C11H26FN7O3; [M+H]+; delta(ppm) 4.755545
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.542; C15H30FNO5; [M+H]+; delta(ppm) -3.526967
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.735; C11H29N7O2S; [M+H]+; delta(ppm) -2.117876
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.105; C16H27N4O3; [M+H]+; delta(ppm) 4.138639
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.536; C16H31F2NOS; [M+H]+; delta(ppm) 0.666066
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C18H29NO4; [M+H]+; delta(ppm) -0.002629
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.583; AKLNLVOZXMQGSI-UHFFFAOYNA-N; [M+H]+; bufetolol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.535; JTRRPZVFSRBZIV-UHFFFAOYSA-N; [M+H]+; 5-{[(3-hydroxypropyl)amino]methyl}-10,14-dimethyl-2,7-dioxatetracyclo[8.4.0.0?,?.0?,?]tetradecan-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.501; SQDFUMNRZHDLGQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-5,5-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.501; PKMWXNTYYZTJQQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylamino)ethoxy]carbonyl}-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.642; IBZYPBGPOGJMBF-VOTSOKGWNA-N; [M+H]+; N-Jasmonoylisoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.461; JNDJPKHYZWRRIS-UHFFFAOYNA-N; [M+H]+; cicloprolol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.452; JKVULIFEVYXDTC-UHFFFAOYSA-N; [M+H]+; 4-({[(3-ethoxy-4-methoxyphenyl)methyl]amino}methyl)-2,2-dimethyloxan-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.433; ZHMNKOPAHVBXQW-SYSZZGASNA-N; [M+H]+; Lycofawcine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.424; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; guaiapate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.410; WGYOXLHUEHBVOF-UHFFFAOYSA-N; [M+H]+; 1-[4-(1-hydroxypropyl)-2-methoxyphenoxy]-3-(piperidin-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.381; SFLJQCLAPBTFNR-BPRAKBJFNA-N; [M+H]+; Brevisamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; FFRMROQLCVKCCL-PUWZGUPBSA-N; [M+H]+; Bipolamide A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; RNJWVOJSSZQWNZ-KPKJPENVSA-N; [M+H]+; 3-tigloyloxy-6-methylbutyryloxytropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; LWJJYAYQOTXATC-IZZDOVSWSA-N; [M+H]+; 3-tigloyloxy-6-(2'-methylbutyryloxy)tropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; NUHKGPDBRUDFLM-PHYFOSRJNA-N; [M+H]+; UNPD186010
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; VOZGUTOOTJYSLX-NJCZDKFDNA-N; [M+H]+; UNPD177764
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; RQTCBECAUUINSD-GXGMXFMGNA-N; [M+H]+; UNPD95697
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; NLDRTHCIVHPBQA-OXMGLSMJNA-N; [M+H]+; UNPD92339
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; MGGGOCSKDLGISA-UHFFFAOYSA-N; [M+H]+; 3-oxo-N-(2-oxooxolan-3-yl)tetradec-7-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; VLKLZZGHWBZISX-UHFFFAOYSA-N; [M+H]+; 3,5-di-tert-butyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; CZCNCPSVLLDKPE-UHFFFAOYSA-N; [M+H]+; 18-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; ZSFRGYXNXUCYAK-PDBXOOCHSA-N; [M+H]+; (9Z,12Z,15Z)-2-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; BDUIIOHQSYPXRT-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-{2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; MLVLRGDKFVUVPM-UHFFFAOYSA-N; [M+H]+; 2-{[2-(dimethylamino)ethoxy]carbonyl}-4-(4-methylpent-3-en-1-ylidene)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; AZDHNVVDNXRURH-UHFFFAOYSA-N; [M+H]+; 6-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-2,3-dimethyl-5-(2-methylprop-1-en-1-yl)cyclohex-3-ene-1-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; SVDGTPCLQKGRJP-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-(3-hydroxy-2-methoxypyrrolidin-1-yl)-4,8-dimethylundeca-3,6,8-trien-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; MXAJYBDSRMKKOJ-UHFFFAOYSA-N; [M+H]+; N-{3,5a,9-trimethyl-2-oxo-dodecahydronaphtho[1,2-b]furan-8-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; MICLDTZEBPLQFX-UHFFFAOYSA-N; [M+H]+; l-isoleucine, n-[[(1s,3as,6r,7as)-6-ethyl-2,3,3a,6,7,7a-hexahydro-1-hydroxy-1h-inden-4-yl]carbonyl]-
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.277; SHTWMNOBENSPNY-UHFFFAOYSA-N; [M+H]+; 3-{[(3-hydroxypropyl)amino]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PKMWXNTYYZTJQQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylamino)ethoxy]carbonyl}-8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SQDFUMNRZHDLGQ-UHFFFAOYSA-N; [M+H]+; 3-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-5,5-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; AKLNLVOZXMQGSI-UHFFFAOYNA-N; [M+H]+; bufetolol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IBZYPBGPOGJMBF-VOTSOKGWNA-N; [M+H]+; N-Jasmonoylisoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SFLJQCLAPBTFNR-BPRAKBJFNA-N; [M+H]+; Brevisamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZHMNKOPAHVBXQW-SYSZZGASNA-N; [M+H]+; Lycofawcine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JNDJPKHYZWRRIS-UHFFFAOYNA-N; [M+H]+; cicloprolol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; guaiapate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LWJJYAYQOTXATC-IZZDOVSWSA-N; [M+H]+; 3-tigloyloxy-6-(2'-methylbutyryloxy)tropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RNJWVOJSSZQWNZ-KPKJPENVSA-N; [M+H]+; 3-tigloyloxy-6-methylbutyryloxytropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NLDRTHCIVHPBQA-OXMGLSMJNA-N; [M+H]+; UNPD92339
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NUHKGPDBRUDFLM-PHYFOSRJNA-N; [M+H]+; UNPD186010
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RQTCBECAUUINSD-GXGMXFMGNA-N; [M+H]+; UNPD95697
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VOZGUTOOTJYSLX-NJCZDKFDNA-N; [M+H]+; UNPD177764
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CZCNCPSVLLDKPE-UHFFFAOYSA-N; [M+H]+; 18-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZSFRGYXNXUCYAK-PDBXOOCHSA-N; [M+H]+; (9Z,12Z,15Z)-2-nitrooctadeca-9,12,15-trienoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FFRMROQLCVKCCL-PUWZGUPBSA-N; [M+H]+; Bipolamide A
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AZDHNVVDNXRURH-UHFFFAOYSA-N; [M+H]+; 6-{[2-(dimethylazaniumyl)ethoxy]carbonyl}-2,3-dimethyl-5-(2-methylprop-1-en-1-yl)cyclohex-3-ene-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BDUIIOHQSYPXRT-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-{2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]acetamido}pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JKVULIFEVYXDTC-UHFFFAOYSA-N; [M+H]+; 4-({[(3-ethoxy-4-methoxyphenyl)methyl]amino}methyl)-2,2-dimethyloxan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JTRRPZVFSRBZIV-UHFFFAOYSA-N; [M+H]+; 5-{[(3-hydroxypropyl)amino]methyl}-10,14-dimethyl-2,7-dioxatetracyclo[8.4.0.0?,?.0?,?]tetradecan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MGGGOCSKDLGISA-UHFFFAOYSA-N; [M+H]+; 3-oxo-N-(2-oxooxolan-3-yl)tetradec-7-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MICLDTZEBPLQFX-UHFFFAOYSA-N; [M+H]+; l-isoleucine, n-[[(1s,3as,6r,7as)-6-ethyl-2,3,3a,6,7,7a-hexahydro-1-hydroxy-1h-inden-4-yl]carbonyl]-
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MLVLRGDKFVUVPM-UHFFFAOYSA-N; [M+H]+; 2-{[2-(dimethylamino)ethoxy]carbonyl}-4-(4-methylpent-3-en-1-ylidene)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MXAJYBDSRMKKOJ-UHFFFAOYSA-N; [M+H]+; N-{3,5a,9-trimethyl-2-oxo-dodecahydronaphtho[1,2-b]furan-8-yl}-2-methoxyacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SHTWMNOBENSPNY-UHFFFAOYSA-N; [M+H]+; 3-{[(3-hydroxypropyl)amino]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SVDGTPCLQKGRJP-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-(3-hydroxy-2-methoxypyrrolidin-1-yl)-4,8-dimethylundeca-3,6,8-trien-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VLKLZZGHWBZISX-UHFFFAOYSA-N; [M+H]+; 3,5-di-tert-butyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WGYOXLHUEHBVOF-UHFFFAOYSA-N; [M+H]+; 1-[4-(1-hydroxypropyl)-2-methoxyphenoxy]-3-(piperidin-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.507; AKLNLVOZXMQGSI-UHFFFAOYSA-N; [M+H]+; 1-(tert-butylamino)-3-[2-(oxolan-2-ylmethoxy)phenoxy]propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.266; JNDJPKHYZWRRIS-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-(cyclopropylmethoxy)ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; AFZPMFFKUZAFPS-UHFFFAOYSA-N; [M+H]+; 2-(diethylamino)ethyl 2-butoxy-3-methoxybenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; GUKYZZSKXIILLI-UHFFFAOYSA-N; [M+H]+; 2-(butylamino)ethyl 2-butoxy-3-methoxybenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; IBZYPBGPOGJMBF-QRHMYKSGSA-N; [M+H]+; (2S,3S)-3-methyl-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.732; XFLILAJQDVNDTB-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.647; PPVFOZYARYOARE-UHFFFAOYSA-N; [M+H]+; 1-[2-[2-[2-(2-methoxyphenoxy)ethoxy]ethoxy]ethyl]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; JNLHPPFPJXHLKE-UHFFFAOYSA-N; [M+H]+; methyl 2-[2-hydroxy-3-(propan-2-ylamino)propoxy]-6-methyl-3-propan-2-ylbenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; RNPFYZLWVMKCHI-BUSXIPJBSA-N; [M+H]+; [(7S)-7-pentanoyloxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl pentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; SNFZSVZRZFZVIV-UHFFFAOYSA-N; [M+H]+; ethyl 2-[3-(dimethylamino)-2-hydroxypropoxy]-6-methyl-3-propan-2-ylbenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; PIEVOKXIIFZVQL-UONOGXRCSA-N; [M+H]+; [(7S,8R)-7-(2,2-dimethylpropanoyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2,2-dimethylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CCMGNXCIXYOAOL-UHFFFAOYSA-N; [M+H]+; 1-[3-(ethoxymethyl)-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; KFJRWDSGXLCBSG-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propylamino)propoxy]-3-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CAAJQOXWAVAKRL-HMXJURRTSA-N; [M+H]+; 2-(dimethylamino)ethyl (2E)-2-[(6S)-6-acetyloxy-3,4,4a,5,6,7,8,8a-octahydro-1H-naphthalen-2-ylidene]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CCOJZFVKVMICEM-UHFFFAOYSA-N; [M+H]+; 1-[2-[2-hydroxy-3-(propan-2-ylamino)propoxy]-5-(propoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; SJCMIKOLENLLHD-UHFFFAOYSA-N; [M+H]+; 1-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3-(propan-2-yloxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; IEFBSRPZXVDVKT-UHFFFAOYSA-N; [M+H]+; 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-(ethoxymethyl)phenyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; KCMGSZLKKRVNKG-UHFFFAOYSA-N; [M+H]+; ditert-butyl 4-prop-2-ynylpiperidine-1,4-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; XCYDUFDZEYUXTG-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-7-[(2-methylpropan-2-yl)oxycarbonylamino]adamantane-1-carboxylic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C18H30N1O4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 27.593
MS$FOCUSED_ION: PRECURSOR_M/Z 324.216934
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0209000000-ff1b8d5e5a028d85bc6b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  149.0234515 464.7567 149.023350 1.8118 115.07 1.0000 108 f{C8H5O3}/0.88ppm,p-C10H25N1O1
  324.2498677 999.0000 324.249660 2.5721 62.67 0.2595 103 ?
  324.2878977 910.0595 324.287690 2.0476 125.82 0.3548 101 ?
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  149.023452 464.76 464
  324.249868 999.00 999
  324.287898 910.06 910
//
